IBRX
IMMUNITYBIO INC
Health Care·Biotechnology·UNITED STATES
$8.71
MCap $9.1B
as of 2026-06-26
Total
B1w
Fund
C1w
Quant
A1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
+1.19
Sentiment 8.3%— short zone
−3 oversold0+3 overbought
Signal
BULLISH
Actual
$8.71
Adaptive Mean
$8.07
+0.64 vs mean
Adaptive σ
0.27
MIDOS BB
$7.54 – $8.61
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.73
ROE
—
Z —
Rev Gr
167.6%
Z +1.11
EPS Gr
38.7%
Z +0.07
OPM Gr
59.5%
Z +0.05
FCF Yld
-3.8%
Z -0.15
EPS Surp
-798.6%
Z -5.64
EPS 3mo Δ
-1.7%
Z +0.16
Fwd P/E
145.17
Z —
PEGY
3.75
Expensive
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
-0.56
Q6M
13.72
Q12M
6.68
MA 30/100
0.966
Bearish (MA30 < MA100)
α (Jensen)
-0.0836
β (12M)
1.86
σ (12M)
1.049
Divergence — Fundamentals vs Momentum
Z Percentile
6%
Q Percentile
87%
Divergence
-80.9
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
308.2
RS Pctl
99%
RS Decile
D10
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.